iberdomide,idecabtagene vicleucel,bortezomib,lenalidomide
2seventy bio,bms,takeda
['kudos', '220,mm,001', 'karmma', 'karmma-2', 'mmsm', 'ide-cel', 'borte']
karmma-2a cohort of ide-cel in pts with early relapse in #mmsm. this is a tough group of patients - kudos to investigators for enrolling! pfs and dor seem fairly similar to later lines. we need to do better for this population! #ash22 
Asst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. https://t.co/mPeWg1QRrW